Skip to main content

Grace Bio-Labs Inks Deal for Avantra's Path Slides

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Grace Bio-Labs today announced a manufacturing and distribution deal for Avantra Biosciences' Path protein microarray ultra-thin non-porous nitrocellulose slides.

The Path Slides provide many of the benefits of nitrocellulose "in a thin film that allows very low background fluorescence and excellent signal-to-noise ratio," Grace Bio-Labs said in a statement. The Bend, Ore., firm also offers its own Oncyte porous nitrocellulose thin film slides, which it says offers the highest binding capacity for protein applications.

Grace Bio-Labs will sell the Path slides directly from its website and through a distribution agreement with Sigma-Aldrich, which also distributes other Grace Bio-Labs products.

Financial and other terms of the deal were not released.

Grace Bio-Labs develops and manufactures products for protein and cell analysis research.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.